These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6151268)

  • 21. Captopril attenuates pressor responses to norepinephrine and vasopressin through depletion of endogenous angiotensin II.
    Imai Y; Abe K; Seino M; Haruyama T; Tajima J; Yoshinaga K; Sekino H
    Am J Cardiol; 1982 Apr; 49(6):1537-9. PubMed ID: 7041592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of captopril and bradykinin on arterial pressure in rats with mestranol-induced hypertension.
    Johnson JA; Dostal DE
    Contraception; 1986 Sep; 34(3):303-10. PubMed ID: 3539511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
    Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
    Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of captopril on blood pressure and bradykinin vasodepressor responses after nephrectomy and suppression of prostaglandin synthesis in anaesthetized rats.
    Vandongen R; Barden A; Tunney A; Mahoney D
    Clin Exp Pharmacol Physiol; 1981; 8(5):473-6. PubMed ID: 7035038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.
    Fenoy FJ; Scicli G; Carretero O; Roman RJ
    Hypertension; 1991 Jun; 17(6 Pt 2):1038-44. PubMed ID: 1646165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolongation of the saralasin responsive state of two-kidney, one clip Goldblatt hypertension in the rat by the orally administered converting enzyme inhibitor captopril (SQ14,225).
    Weed WC; Vaughan ED; Peach MJ
    Hypertension; 1979; 1(1):8-12. PubMed ID: 397195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenal angiotensin II receptors and vascular reactivity to angiotensin II in the rat during continuous inhibition of angiotensin converting enzyme.
    Millar JA; Casey DJ; Johnston CI
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():65s-69s. PubMed ID: 6256119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Captopril potentiates depressor responses to arachidonic acid in the rat.
    Hui SC; Boura AL
    Clin Exp Pharmacol Physiol; 1982; 9(6):679-83. PubMed ID: 6819911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of bradykinin-induced reflex tachycardia to bradycardia by captopril; evidence for prostacyclin involvement.
    Waldron TL; Antonaccio MJ; Murthy VS
    Eur J Pharmacol; 1982 Apr; 79(3-4):283-92. PubMed ID: 6807698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the bradykinin antagonist B4310 on smooth muscles and blood pressure in the rat, and its enzymatic degradation.
    Griesbacher T; Lembeck F; Saria A
    Br J Pharmacol; 1989 Mar; 96(3):531-8. PubMed ID: 2655805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
    Johnston CI; Clappison BH; Anderson WP; Yasujima M
    Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
    Clappison BH; Anderson WP; Johnston CI
    Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.
    Drapeau G; deBlois D; Marceau F
    J Pharmacol Exp Ther; 1991 Dec; 259(3):997-1003. PubMed ID: 1662280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of a role of circulating bradykinin in the blood pressure response to acute angiotensin converting enzyme inhibition in rats.
    Aubert JF; Waeber B; Nussberger J; Vavrek R; Stewart JM; Brunner HR
    Agents Actions Suppl; 1987; 22():349-54. PubMed ID: 3324717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypotensive action of captopril in spontaneously hypertensive and normotensive rats. Interference with neurogenic vasoconstriction.
    Clough DP; Hatton R; Keddie JR; Collis MG
    Hypertension; 1982; 4(6):764-72. PubMed ID: 6292083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of infused captopril on blood pressure and the renin-angiotensin-aldosterone system in normal dogs subjected to varying sodium balance.
    Morton JJ; Tree M; Casals-Stenzel J
    Am J Cardiol; 1982 Apr; 49(6):1395-400. PubMed ID: 7041583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Converting enzyme inhibition and vascular prostacyclin synthesis: effect of kinin receptor antagonism.
    Hoffmann G; Pietsch R; Göbel BO; Weisser B; Bönner G; Vetter H; Düsing R
    Eur J Pharmacol; 1990 Mar; 178(1):79-83. PubMed ID: 2158900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Converting enzyme inhibition and modulation of plasma renin activity with captopril in anesthetized rats.
    Suzuki M; Satoh S
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):121-36. PubMed ID: 6275810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of the blood pressure and renal hemodynamic effects of captopril.
    Hall JE; Granger JP
    Am J Cardiol; 1982 Apr; 49(6):1527-9. PubMed ID: 7041591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of the effects of insulin, bradykinin, and captopril on blood glucose levels of alloxan-diabetic rats.
    Jaffa AA; Pratt J; Ashford A; Bailey GS
    Adv Exp Med Biol; 1986; 198 Pt B():373-8. PubMed ID: 3028079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.